facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory

    Kraków, Poland – June 06, 2016 – The European Lead Factory, a scientific consortium dedicated to supporting the discovery of innovative medicines, has selected the first drug target program from Poland, to perform high throughput screening. The selec…

    Read More...

  • Selvita to present at the Annual BIO International Convention 2016

    Krakow, 27 May 2016 - Selvita S.A. (WSE: SLV), the largest drug discovery company in Central and Eastern Europe, will participate and present at the upcoming Annual BIO International Convention, taking place on June 6-9, 2016, at the Moscone Center i…

    Read More...

  • Selvita enjoys 36% business growth in Q1 2016

    Krakow, Poland - May 16, 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has generated strong revenue growth in the first quarter of 2016. Net sales revenues (excluding grants) amounted to PLN 11.4 MM, as compared to…

    Read More...